"on small cell lung cancer" trang 10 - tải miễn phí từ tailieunhanh
Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: A meta-analysis

Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: A meta-analysis
12    76    0
Impact of viral presence in tumor on gene expression in non-small cell lung cancer

Impact of viral presence in tumor on gene expression in non-small cell lung cancer
13    72    0
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial

Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial
11    81    0
The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients
9    41    1
Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment

Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment
8    40    1
High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer

High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer
8    49    1
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer

Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer
8    69    1
An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy

An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy
10    41    1
The effect of low insurance reimbursement on quality of care for non-small cell lung cancer in China: A comprehensive study covering diagnosis, treatment, and outcomes

The effect of low insurance reimbursement on quality of care for non-small cell lung cancer in China: A comprehensive study covering diagnosis, treatment, and outcomes
10    50    1
Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis

Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis
8    40    1
Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: A retrospective observational study with use of a national database in Japan

Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: A retrospective observational study with use of a national database in Japan
6    67    1
Benefits of home-based multidisciplinary exercise and supportive care in inoperable non-small cell lung cancer – protocol for a phase II randomised controlled trial

Benefits of home-based multidisciplinary exercise and supportive care in inoperable non-small cell lung cancer – protocol for a phase II randomised controlled trial
12    70    1
Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer

Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer
12    69    1
Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): Findings from a real-world setting

Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): Findings from a real-world setting
8    80    1
Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer

Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer
11    87    1
A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506)

A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506)
7    65    1
Frequency of the acquired resistant mutation T790 M in non-small cell lung cancer patients with active exon 19Del and exon 21 L858R: A systematic review and meta-analysis

Frequency of the acquired resistant mutation T790 M in non-small cell lung cancer patients with active exon 19Del and exon 21 L858R: A systematic review and meta-analysis
7    47    1
Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)

Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)
10    65    1
Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/ PPARγ/PTEN/mTOR signaling pathway

Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/ PPARγ/PTEN/mTOR signaling pathway
10    68    1
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer

A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer
8    62    1